Genomics in 2016: Nathan and Laura Name Their Top Stories
www.mendelspod.com
From new CRISPR trials in humans to mitochondrial transfer therapy, from the spinout by Illumina of two new genomics health companies to the complete and utter failure of Theranos, from the approval by the FDA of GM mosquitos to the FDA giving up on LDT regulation as a result of the election, the genomics headlines of 2016 didn’t fail to dazzle, deliver, and disappoint.
Genomics in 2016: Nathan and Laura Name Their Top Stories
Genomics in 2016: Nathan and Laura Name Their…
Genomics in 2016: Nathan and Laura Name Their Top Stories
From new CRISPR trials in humans to mitochondrial transfer therapy, from the spinout by Illumina of two new genomics health companies to the complete and utter failure of Theranos, from the approval by the FDA of GM mosquitos to the FDA giving up on LDT regulation as a result of the election, the genomics headlines of 2016 didn’t fail to dazzle, deliver, and disappoint.